Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
NCT ID | NCT02365766 |
Title | Study of Neoadjuvant Pembrolizumab in Combination With Gemcitabine Based Therapy in Cis-eligible or -Ineligible Subjects With Urothelial Cancer |
Recruitment | Active, not recruiting |
Gender | both |
Phase | Phase Ib/II |
Variant Requirements | No |
Sponsors | Christopher Hoimes, M.D. |
Indications | |
Therapies | |
Age Groups: | adult |
Covered Countries | USA |
Facility | Status | City | State | Zip | Country | Details |
---|---|---|---|---|---|---|
Indiana University Melvin and Bren Simon Cancer Center | Indianapolis | Indiana | 46202 | United States | Details | |
IU Health Central Indiana Cancer Center | Indianapolis | Indiana | 46219 | United States | Details | |
Community Regional Cancer Care | Indianapolis | Indiana | 46256 | United States | Details | |
St. Vincent Hospital | Indianapolis | Indiana | 46260 | United States | Details | |
Washington University: Siteman Cancer Center | Saint Louis | Missouri | 63110 | United States | Details | |
University of New Mexico Cancer Center | Albuquerque | New Mexico | 87106 | United States | Details | |
University Hospitals Seidman Cancer Center | Cleveland | Ohio | 44106 | United States | Details | |
Thomas Jefferson University: Kimmel Cancer Center | Philadelphia | Pennsylvania | 19107 | United States | Details | |
Virginia Oncology Associates | Norfolk | Virginia | 23502 | United States | Details |